Ken Fisher's position in Veracyte is currently worth $23.8M. That's 0.01% of their equity portfolio (305th largest holding). The first Veracyte trade was made in Q1 2021. Since then Ken Fisher bought shares ten more times and sold shares on seven occasions. The investor's estimated purchase price is $26.2M, resulting in a loss of 9.0%.